EMR701173_002, NCT01653743: Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women |
|
|
| Completed | 3 | 81 | Japan | MSJ-0011, urinary hCG (u-hCG), Follitropin alpha | Merck KGaA, Darmstadt, Germany, Merck Serono Co., Ltd., Japan | Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction, Polycystic Ovarian Syndrome | 11/14 | 12/14 | | |
| Terminated | 2/3 | 60 | Canada | Saizen (Human Growth Hormone), No Saizen Control (Standard IVF Protocol) | Pacific Centre for Reproductive Medicine, EMD Serono | Infertility | 06/15 | 08/15 | | |
